Lipoprotein(a) does not correlate with hypertensive mediated organ damage and subsequent cardiovascular events in a primary prevention cohort
European Atherosclerosis Journal · 30.04.2026 · 5 (1) · 25
DOI: 10.56095/eaj.v5i1.133 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Atherosclerosis Journal, online erschienen am 30.04.2026. Verfasst von Beatrice Invernici und 21 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
Elevated lipoprotein(a) [Lp(a)] levels have been strongly related to cardiovascular (CV) risk. However, its association with Hypertension Mediated Organ Damage (HMOD) and CV events in the primary prevention setting remains unclear. The aim of our study is to evaluate in these patients the correlation between Lp(a) levels and: (i) heart, vessels and kidney HMOD and; (ii) CV events and all-cause mortality in a primary prevention setting.
Methods
747 low CV risk subjects were recruited between 2009 and 2014. HMOD was assessed through Pulse Wave Velocity (PWV), carotid Intima-Media Thickness (IMT), presence of carotid plaques, Left Ventricular Hypertrophy (LVH), Ejection Fraction (EF) and glomerular filtration rate (GFR). All-cause mortality and CV events up to 2021 were retrieved by electronic health records, for a median follow-up time of 10 years (I-III quartiles 9.6-11.1).
Results
Mean age was 50.8 ± 13.0 years and 63.5% of the subjects were men. The prevalence of hypertension was 37.9%, dyslipidemia 67.2%, smoking 17.8%, and diabetes mellitus 8.7%. Median Lp(a) value was 17 mg/dL (5.9–56.0), and 26.5% of patients had values above 50 mg/dL. Regarding HMOD, 10.3% subjects had arterial stiffness, 7.2% increased IMT, 19.8% carotid plaques while only 0.7% had LVH. No significant correlation was found between Lp(a) levels and indices of subclinical HMOD. Furthermore, no relationship was found between CV events and all-cause mortality and Lp(a) levels.
Conclusions
In this primary prevention cohort, elevated Lp(a) levels were not associated with significant structural damage to the heart, carotid arteries, or increased aortic stiffness and were not associated with CV events and all-cause mortality.
Zitieren
APA
Invernici, B., Tognola, C., Bernasconi, D. P., Rebora, P., Intravaia, R. C. M., Mancusi, C., Visco, V., Cesaro, A., Golia, E., Fucile, I., Merlini, P., Ardissino, M., Inglese, E., Danesi, R., Oliva, F., Andreano, A., Rognoni, M., Russo, A., Calabrò, P., …, & Maloberti, A. (2026). Lipoprotein(a) does not correlate with hypertensive mediated organ damage and subsequent cardiovascular events in a primary prevention cohort. European Atherosclerosis Journal, 5(1), 25. https://doi.org/10.56095/eaj.v5i1.133
Vancouver
Invernici B, Tognola C, Bernasconi DP, Rebora P, Intravaia RCM, Mancusi C, et al. Lipoprotein(a) does not correlate with hypertensive mediated organ damage and subsequent cardiovascular events in a primary prevention cohort. European Atherosclerosis Journal. 2026;5(1):25. doi:10.56095/eaj.v5i1.133
BibTeX
@article{Invernici2026,
author = {Invernici, Beatrice and Tognola, Chiara and Bernasconi, Davide Paolo and Rebora, Paola and Intravaia, Rita Cristina Myriam and Mancusi, Costantino and Visco, Valeria and Cesaro, Arturo and Golia, Enrica and Fucile, Ilaria and Merlini, Piera and Ardissino, Maddalena and Inglese, Elvira and Danesi, Romano and Oliva, Fabrizio and Andreano, Anita and Rognoni, Magda and Russo, Antonio and Calabrò, Paolo and Luca, Nicola De and Giannattasio, Cristina and Maloberti, Alessandro},
title = {Lipoprotein(a) does not correlate with hypertensive mediated organ damage and subsequent cardiovascular events in a primary prevention cohort},
journal = {European Atherosclerosis Journal},
year = {2026},
volume = {5},
number = {1},
pages = {25},
doi = {10.56095/eaj.v5i1.133}
}
EUVIMED